Repigmentation Failure in Acral Vitiligo: A Comprehensive Review of Anatomical Resistance, Follicular Melanocyte Reservoirs, and Treatment Outcomes
Background: Vitiligo is a common autoimmune depigmenting disorder in which the hands and feet are among the most frequently involved and most visible sites. Across phototherapy, topical immunomodulators, Janus kinase (JAK) inhibitors, and procedural therapies, acral lesions repigment less often, more slowly, and less completely than facial or truncal lesions. The reasons are incompletely understood, and the term "acral" is applied to anatomically dissimilar regions. Objective: To synthesize anatomical, cellular, immunological, and clinical evidence explaining repigmentation failure in acral vitiligo and to evaluate which therapeutic approaches produce meaningful outcomes at these sites. Methods: Comprehensive (non-systematic) review of PubMed/MEDLINE, Europe PMC, and ClinicalTrials.gov from inception to 23 October 2026, supplemented by citation tracking and bibliographic verification through CrossRef and OpenAlex. Site-stratified data were extracted from primary studies, trial subgroup analyses, and research letters. Findings: Acral skin is heterogeneous: dorsal hands and feet retain sparse hair follicles, whereas fingertips, periungual skin, palms, and soles are essentially follicle-free; glabrous skin also has a thick stratum corneum, lower melanocyte density, and fibroblasts that express the Wnt inhibitor dickkopf-1. Histological and clinical data link poor acral responses to reduced follicular melanocyte reservoirs and to impaired stem cell factor/KIT signalling, and repigmentation that does occur is concentrated on dorsal surfaces rather than digit tips. Site-stratified analyses show consistent gradients: no marked responses on hands and feet in a phototherapy meta-analysis, 52-week VASI50 rates of 38.2% (hands) and 29.3% (feet) with ruxolitinib cream versus 68.1% for head and neck, and similar ordering with oral JAK inhibitors. Koebnerization, persistent tissue-resident memory T cells, and site-specific immune responses add a second, destructive component. Cellular grafting partially overcomes the reservoir deficit in stable disease, although fingertip involvement predicts later relapse. Limitations: Evidence is dominated by small, single-centre studies with heterogeneous definitions of acral involvement and outcome measures; most mechanistic data are indirect. Conclusions: Acral repigmentation failure appears to result from interacting deficits in melanocyte supply, regenerative signalling, drug and light delivery, and immune persistence. Realistic counselling, subsite- specific expectations, early stabilisation, combination strategies, and timely consideration of grafting in stable disease are supported; acral-specific trials with standardized endpoints are needed.
Authors
- Saud Abdullah Ali Alsharif
Publication Details
- Journal
- HAL
- Published
- 2026-11-14
- DOI
- https://doi.org/10.59324/jcpmr.2026.2(6).10
- Primary Topic
- melanin and skin pigmentation
- Type
- article
- Field-Weighted Citation Impact
- 0.00